TMS refers to the treatment of psychiatric and neurological disorders such as anxiety, migraine, post traumatic stress disorder, schizophrenia, obsessive-compulsive disorder and depression and is a neurophysiological procedure for noninvasive stimulation of the nervous system. An FDA-approved treatment that causes long-term inhibition and excitation of neurons in certain superficial brain areas, TMS has undergone significant research in recent years.

TMS supersedes electroconvulsive therapy (ECT) as it bypasses the skull and can be applied to specific areas of the brain. The process involves the application of a repetitive magnetic field to the superficial layers of the cerebral cortex. This induces small electric Eddy or Foucault currents at a local position with the cerebral cortex acting as a secondary coil. There is no need for patient anaesthesia or sedation and lower stimulus strengths produce a similar or better effect than ECT in a shorter timespan. The use of low frequency stimulation produces an inhibitory effect, while higher frequencies perform excitatory stimulation, so increasing or decreasing neuronal excitation over the long-term. Remission of mood and neurological disorders and a decrease in suicidal tendencies are proven with little (scalp discomfort during treatment) to no side-effects.

Zone Medical is proud to supply the Ates Medical STM9000 TMS to certified neurologists, psychologists and cognitive neuroscience researchers. Ates is a manufacturer and distributor of medical devices, specialized in the fields of cardiology and neurology. The Ates STM9000 repetitive TMS machine is ISO 9001 and ISO 13485 certified and available at Zone Medical in three models: Standard, Fast and Ultrafast. These options refer to each machine’s stimulation frequencies per second.

Showing the single result

Zone Medical